Dr. Eliza Hawkes
1 clinical trials · Sponsor
| Record | Firm | Date |
|---|---|---|
| Nivolumab Plus Rituximab in First-line Follicular Lymphoma gr 1-3A (NCT03245021) | Dr. Eliza Hawkes | 2017-09-07 |
Track Dr. Eliza Hawkes automatically
Every clearance here is in the API, with alerts when new ones post.